Literature DB >> 26909897

Relationship between TLR4 and CCL2 expression and recurrent spontaneous abortion.

P Li1,2, H L Wu2, B H Dong1.   

Abstract

The increasing incidence of recurrent spontaneous abortion (RSA) severely affects women's health. The involvement of the immune system during pregnancy and its contribution to RSA draw researchers' attention. Both Toll-like receptor 4 (TLR4) and chemokine (C-C motif) ligand 2 (CCL2) have been linked to various pregnancy disorders. In this study, we quantified TLR4 and CCL2 levels in a case-control study in order to elucidate the correlation between these factors and RSA, and the potential to use them as disease markers. A total of 36 RSA patients and 36 healthy control individuals were recruited for the donation of decidual and chorionic tissues and venous blood samples. Fluorescent quantitative-polymerase chain reaction was used to measure mRNA levels and enzyme linked immunosorbent assay was used to quantify serum levels of TLR4 and CCL2. RSA patients had higher TLR4 and CCL2 mRNA levels compared to controls (P < 0.05). Serum levels of the two factors were also significantly higher in RSA patients than in the control group (P < 0.05). Positive correlations were found between serum levels and tissue mRNA levels of TLR4 and CCL2. In conclusion, both TLR4 and CCL2 were closely related to the occurrence of RSA, suggesting that serum TLR4 and CCL2 levels could be used as indices for monitoring RSA in pregnant women.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26909897     DOI: 10.4238/gmr.15016882

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  8 in total

1.  Estradiol Suppresses TLR4-triggered Apoptosis of Decidual Stromal Cells and Drives an Anti-inflammatory TH2 Shift by Activating SGK1.

Authors:  Yiyun Lou; Minhao Hu; Qijing Wang; Mu Yuan; Ning Wang; Fang Le; Lejun Li; Shisi Huang; Liya Wang; Xiangrong Xu; Fan Jin
Journal:  Int J Biol Sci       Date:  2017-03-11       Impact factor: 6.580

2.  Cytokines in relation to hCG are significantly altered in asymptomatic women with miscarriage - a pilot study.

Authors:  Alexander Freis; Janina Schlegel; Volker Daniel; Julia Jauckus; Thomas Strowitzki; Ariane Germeyer
Journal:  Reprod Biol Endocrinol       Date:  2018-09-28       Impact factor: 5.211

3.  Maternal-Fetal Conflict During Infection: Lessons From a Mouse Model of Placental Malaria.

Authors:  Yash Pandya; Carlos Penha-Gonçalves
Journal:  Front Microbiol       Date:  2019-05-24       Impact factor: 5.640

4.  CD4+CD25+Foxp3+ regulatory T cells regulate immune balance in unexplained recurrent spontaneous abortion via the Toll-like receptor 4/nuclear factor-κB pathway.

Authors:  Shuang Qin; Li Li; Jia Liu; Jinrui Zhang; Qing Xiao; Yujuan Fan; Xiangcai Wei
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

5.  Proteomic Analysis of Differentially Expressed Proteins in the Placenta of Anticardiolipin Antibody- (ACA-) Positive Pregnant Mice after Anzi Heji Treatment.

Authors:  Yazhen Xie; Qibin Lu
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-14       Impact factor: 2.629

6.  The Pharmacological Activity of the Wenjing Decoction in Recurrent Spontaneous Abortion.

Authors:  Linhui Cao; Hui Chen; Yanxia Huang; Liudan Chen; Mengru Kang; Junxiong Liang
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-13       Impact factor: 2.629

7.  TLR4-Endothelin Axis Controls Syncytiotrophoblast Motility and Confers Fetal Protection in Placental Malaria.

Authors:  Yash Pandya; Alexander Marta; André Barateiro; Carla Letícia Bandeira; Jamille Gregório Dombrowski; João Costa; Cláudio Romero Farias Marinho; Carlos Penha-Gonçalves
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

Review 8.  Collagen at the maternal-fetal interface in human pregnancy.

Authors:  Jia-Wei Shi; Zhen-Zhen Lai; Hui-Li Yang; Shao-Liang Yang; Cheng-Jie Wang; Deng Ao; Lu-Yu Ruan; Hui-Hui Shen; Wen-Jie Zhou; Jie Mei; Qiang Fu; Ming-Qing Li
Journal:  Int J Biol Sci       Date:  2020-05-25       Impact factor: 6.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.